Marché du traitement des dysfonctionnements sexuels féminins
"Concevoir des stratégies de croissance est dans notre ADN"
Female Sexual Dysfunction Treatment Market Size, Share & Industry Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies) et prévisions régionales, 2025-2032
Dernière mise à jour: November 17, 2025
| Format: PDF
| Numéro du rapport: FBI100850